Overview
Informatics will be one of the keys to success for companies applying high-throughput genomic tools to drug discovery and development. A range of new tools are becoming available to researchers seeking to collect, analyze, integrate, and archive data across all R&D activities. More than 80 companies are currently selling software or databases for critical IT-related pharmaceutical R&D tasks, including genomic data analysis, data integration, data storage, ADMET prediction, in silico modeling, or pharmaceutical knowledge management. This report describes the current and emerging roles of informatics in drug discovery and development, the leading tools and those under development, the specific changes ahead in particular fields, and the strategies that companies are pursuing to meet future demands. The report also provides vital business statistics (including financial data) on more than 20 companies, and commentary opinion and strategic insight from over a dozen leading experts in pharmaceutical R&D and life
science informatics.
View Cart
